Effectiveness of acitretin for skin cancer prevention in immunosuppressed and nonimmunosuppressed patients: A retrospective cohort study
Journal of the American Academy of Dermatology · 2024-04 · 90 (4) · 821-822
DOI: 10.1016/j.jaad.2023.11.034 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of the American Academy of Dermatology, 2024-04. Verfasst von Shaman Bhullar und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Yale School of Medicine. Hauptthemen laut MEDLINE: Skin Neoplasms, Basal Cell Carcinoma, Organ Transplantation. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Yale School of Medicine.
- Department of Dermatology, Yale School of Medicine. Electronic address: sean.christensen@yale.edu.
Zitieren
APA
Bhullar, S., & Christensen, S. R. (2024). Effectiveness of acitretin for skin cancer prevention in immunosuppressed and nonimmunosuppressed patients: A retrospective cohort study. Journal of the American Academy of Dermatology, 90(4), 821-822. https://doi.org/10.1016/j.jaad.2023.11.034
Vancouver
Bhullar S, Christensen SR. Effectiveness of acitretin for skin cancer prevention in immunosuppressed and nonimmunosuppressed patients: A retrospective cohort study. Journal of the American Academy of Dermatology. 2024;90(4):821-822. doi:10.1016/j.jaad.2023.11.034
BibTeX
@article{Bhullar2024,
author = {Bhullar, Shaman and Christensen, Sean R},
title = {Effectiveness of acitretin for skin cancer prevention in immunosuppressed and nonimmunosuppressed patients: A retrospective cohort study},
journal = {Journal of the American Academy of Dermatology},
year = {2024},
volume = {90},
number = {4},
pages = {821--822},
doi = {10.1016/j.jaad.2023.11.034}
}
EUVIMED